Global Information
회사소개 | 문의 | 비교리스트

악성빈혈 진단 및 치료 시장(2021-2027년)

Pernicious Anemia Diagnosis and Treatment Market 2021-2027

리서치사 Orion Market Research Pvt Ltd
발행일 2021년 06월 상품코드 1025326
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 5,125 ₩ 7,280,000 Unprintable PDF (Single User License)
US $ 6,625 ₩ 9,411,000 Unprintable PDF (5 User License)
US $ 8,280 ₩ 11,762,000 Printable PDF (Corporate License)


악성빈혈 진단 및 치료 시장(2021-2027년) Pernicious Anemia Diagnosis and Treatment Market 2021-2027
발행일 : 2021년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

악성빈혈 진단 및 치료 시장 규모는 예측 기간 중 7.1%의 대폭적인 CAGR로 확대할 것으로 예측됩니다. 그러나 악성빈혈의 치료제가 고액인 것이 시장의 주요 저해요인입니다. 이에 따라 많은 사람이 이 질병을 방치하고 있습니다. 그러나 정부의 계발 활동이 활발해지면 시장에도 긍정적인 변화를 초래할 것입니다.

악성빈혈 환자는 COVID-19에 감염하면 사망할 가능성이 있습니다. 이것은 비타민 B-12 결핍에 의한 사이토카인 폭풍에 의한 것입니다. 이러한 상황 아래에서 환자의 면역계는 자신의 신체에 대해 작용하기 시작하여 복수의 장기에 데미지를 줍니다. 이러한 장기의 장애는 COVID-19가 치유된 이후에도 환자의 사망을 야기합니다. 이에 따라 세계 각국의 정부 및 의료기관의 큰 관심사가 되고 있습니다.

악성빈혈 진단 및 치료 시장에 대해 조사했으며, 시장의 개요와 진단별, 치료별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 리포트 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 인사이트와 현재의 시장 동향

제3장 경쟁 구도

  • 주요 기업 분석
    • 개요
    • 재무 분석
    • SWOT 분석
    • 최근 동향
  • 주요 전략 분석
  • 주요 기업에 대한 COVID-19의 영향

제4장 시장 결정요인

  • 성장요인
  • 억제요인
  • 시장 기회

제5장 시장 세분화

  • 세계의 악성빈혈 진단 및 치료 시장, 진단별
    • 전혈구 계산 검사
    • 비타민 B-12 결핍증 검사
    • 생검
    • 내인자 결핍증 검사
  • 세계의 악성빈혈 진단 및 치료 시장, 치료별
    • 비타민 B-12 주사
    • 비타민 B-12 필
    • 기타(스프레이)

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타
  • 기타 지역

제7장 기업 개요

  • American Regent, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioVision, Inc.
  • Cleveland HeartLab, Inc.
  • Daiichi Sankyo Co., Ltd.
  • DSM Nutritional Products AG
  • Emisphere Technologies, Inc.
  • Endo Pharmaceuticals Plc.
  • GlaxoSmithKline Plc.
  • Guardian Healthcare Services Pvt. Ltd.
  • Laboratory Corporation of America Holdings
  • Monobind, Inc.
  • Pfizer, Inc.
  • Pharmacosmos A/S
  • Pharmavite, LLC
  • Premier Research Labs
  • Swanson Health Products
  • The Synergy Company
  • Trinity Biotech Plc.
KSA 21.09.09

LIST OF TABLES

  • 1. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL COMPLETE BLOOD COUNT TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL VITAMIN B-12 DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL INTRINSIC FACTOR DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 7. GLOBAL VITAMIN B-12 INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL VITAMIN B-12 PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL OTHER TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 14. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 16. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET, 2021-2027 (%)
  • 4. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2020 VS 2027 (%)
  • 5. GLOBAL COMPLETE BLOOD COUNT TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL VITAMIN B-12 DEFICIENCY TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL BIOPSY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL INTRINSIC FACTOR DEFICIENCY TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2020 VS 2027 (%)
  • 10. GLOBAL VITAMIN B-12 INJECTIONSMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL VITAMIN-B12 PILLSMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. UNITED STATES PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. CANADA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. UK PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. GERMANY PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. SPAIN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. FRANCE PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. ITALY PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. ROE PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. INDIA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. CHINA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. JAPAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. SOUTH KOREA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

Global Pernicious Anemia Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (Complete Blood Count Test, Vitamin B-12 Deficiency Test, Biopsy, and Intrinsic Factor Deficiency Test), By Treatment (Vitamin B-12 Injections, Vitamin B-12 Pills and Other), Forecast Period 2021-2027

The pernicious anemia diagnosis and treatment market is anticipated to grow at a substantial CAGR of 7.1% during the forecast period. The high cost of medical drugs for the treatment of pernicious anemia is the major restraining factor for the market. Due to this reason lots of people neglect the prevalence of this disease. However, the increasing government's effort for generating awareness will bring a positive change in the market.

Patients with pernicious anemia are susceptible to mortality after the COVID-19 infection. This is due to the cytokine storm due to the deficiency of vitamin B-12. Under this situation, the patient's immune system starts working against their body and damages multiple organs. This failure of organs causes the death of patients even after the curing of COVID-19. Due to this reason, it is a matter of great concern for the global governments and health fraternities.

The global pernicious anemia diagnosis and treatment market is segmented based on diagnosis, and treatment. Based on the material, the market is segmented into complete blood count tests, vitamin B-12 deficiency tests, biopsy, and intrinsic factor deficiency tests. Based on the treatment, the market is segmented into vitamin B-12 injections and vitamin B-12 pills. Apart from this, by symptoms, the market is segmented into weight loss, shortness of breath, diarrhea, fatigue, and weakness, and others.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The people of Northern Europe and Africa are more descent to the pernicious anemia. Additionally, it is more prone to elderly people as their stomach capacity is weak to absorb vitamin B-12. The increasing investment of the European government is expected to give considerable growth to the pernicious anemia market in the region.

The competition in the global pernicious anemia diagnosis and treatment market is moderate as the companies present in the market are not so active. The market players are engaged in providing various B-12 vitamin injections, sprays, immunosuppressant drugs, and tests for Intrinsic factor deficiency. The key players in the pernicious anemia market includes American Regent, Inc., Daiichi Sankyo Co, Ltd., Emisphere Technologies, Inc, and so on. The companies are engaged in rapid research and development for the development of effective treatment measures for the disease.

Research Methodology

The market study of the global pernicious anemia diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Pernicious Anemia Diagnosis and Treatment Market Research and Analysis by Diagnosis

Global Pernicious Anemia Diagnosis and Treatment Market Research and Analysis by Treatment

The Report Covers

Comprehensive research methodology of the global pernicious anemia diagnosis and treatment market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global pernicious anemia diagnosis and treatment market.

Insights about market determinants that are stimulating the global pernicious anemia diagnosis and treatment market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Pernicious Anemia Diagnosis and Treatment Market
  • Recovery Scenario of Global Pernicious Anemia Diagnosis and Treatment Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Pernicious Anemia Diagnosis and Treatment Market by Diagnosis
    • 5.1.1. Complete Blood Count Test
    • 5.1.2. Vitamin B-12 Deficiency Test
    • 5.1.3. Biopsy
    • 5.1.4. Intrinsic Factor Deficiency Test
  • 5.2. Global Pernicious Anemia Diagnosis and Treatment Market by Treatment
    • 5.2.1. Vitamin B-12 Injections
    • 5.2.2. Vitamin B-12 Pills
    • 5.2.3. Other (Spray)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. American Regent, Inc.
  • 7.2. Bio-Rad Laboratories, Inc.
  • 7.3. BioVision, Inc.
  • 7.4. Cleveland HeartLab, Inc.
  • 7.5. Daiichi Sankyo Co., Ltd.
  • 7.6. DSM Nutritional Products AG
  • 7.7. Emisphere Technologies, Inc.
  • 7.8. Endo Pharmaceuticals Plc.
  • 7.9. GlaxoSmithKline Plc.
  • 7.10. Guardian Healthcare Services Pvt. Ltd.
  • 7.11. Laboratory Corporation of America Holdings
  • 7.12. Monobind, Inc.
  • 7.13. Pfizer, Inc.
  • 7.14. Pharmacosmos A/S
  • 7.15. Pharmavite, LLC
  • 7.16. Premier Research Labs
  • 7.17. Swanson Health Products
  • 7.18. The Synergy Company
  • 7.19. Trinity Biotech Plc.
Back to Top
전화 문의
F A Q